Lexaria Bioscience First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Lexaria Bioscience ( NASDAQ:LEXX ) First Quarter 2025 Results Key Financial Results Net loss: US$2.70m (loss widened by…

Share this Article:

This article was originally published here.